守住医保基金安全底线

Group 1 - The core viewpoint emphasizes the importance of safeguarding the medical insurance fund, which is crucial for public health, and highlights the severe penalties imposed on medical insurance fraud cases by the Supreme People's Court [1][2] - In 2024, a total of 1,156 medical insurance fraud cases involving 2,299 individuals were concluded in first-instance trials, marking a year-on-year increase of 131.2%, with over 402 million yuan recovered in losses to the medical insurance fund [1] - The article discusses the emergence of new, more covert methods of medical insurance fraud, including the organized illegal trade of "recovered drugs" through social media, which poses significant risks to public health and safety [1] Group 2 - The article calls for enhanced regulatory measures to address the high incidence of medical insurance fraud, indicating that existing oversight mechanisms need to be expanded and updated to cover a broader range of fraudulent activities [2] - It suggests the implementation of advanced regulatory methods, such as artificial intelligence monitoring and big data analysis, to improve the precision and effectiveness of oversight, aiming to prevent losses and ensure the proper use of medical insurance funds [2]